Fourpath Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Fourpath Capital Management's AMGN Position: Q2 2026 in Review
Fourpath Capital Management increased its Amgen (AMGN) stake by 9.9% in Q2 2026, buying an estimated $74.3K and bringing the position to 2,411 shares worth $873K. The position accounts for 0.11% of the portfolio, ranked #128.
Fourpath Capital Management first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.23M in Q3 2023. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Fourpath Capital Management held 2,411 shares of Amgen worth $873K as of Q2 2026.
- Fourpath Capital Management bought 217 Amgen shares in Q2 2026, an estimated $74.3K.
- Amgen made up 0.11% of Fourpath Capital Management's portfolio in Q2 2026, its #128 holding.
- Fourpath Capital Management first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- Fourpath Capital Management's Amgen position peaked at $1.23M in Q3 2023.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Fourpath Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.